Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP4OX in trauma patients with hemorrhagic shock
NCT01262196Phase 2Completed
- Sponsor
- Sangart
- Start
- May 2011
- Primary completion
- Oct 2012
- Countries
- 14
01
Overview
A Phase 2 trial of Hemospan in hemorrhagic shock, lactic acidosis, sponsored by Sangart. Started May 2011; status: completed.
02
Drugs
Hemospan
03
Conditions
hemorrhagic shocklactic acidosis
Beyond the preview
Go deeper on NCT01262196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01262196.